1. Home
  2. PRAX vs PFSI Comparison

PRAX vs PFSI Comparison

Compare PRAX & PFSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Praxis Precision Medicines Inc.

PRAX

Praxis Precision Medicines Inc.

HOLD

Current Price

$299.14

Market Cap

9.6B

Sector

Health Care

ML Signal

HOLD

Logo PennyMac Financial Services Inc.

PFSI

PennyMac Financial Services Inc.

HOLD

Current Price

$88.16

Market Cap

4.8B

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
PRAX
PFSI
Founded
2015
2008
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Finance: Consumer Services
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
9.6B
4.8B
IPO Year
2020
2018

Fundamental Metrics

Financial Performance
Metric
PRAX
PFSI
Price
$299.14
$88.16
Analyst Decision
Strong Buy
Buy
Analyst Count
15
8
Target Price
$572.13
$139.13
AVG Volume (30 Days)
309.6K
707.4K
Earning Date
05-01-2026
04-21-2026
Dividend Yield
N/A
1.38%
EPS Growth
N/A
59.25
EPS
N/A
9.30
Revenue
N/A
$984,629,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$6,395.88
$15.35
P/E Ratio
N/A
$9.39
Revenue Growth
N/A
3.05
52 Week Low
$26.70
$83.66
52 Week High
$354.87
$160.36

Technical Indicators

Market Signals
Indicator
PRAX
PFSI
Relative Strength Index (RSI) 43.28 38.83
Support Level $290.36 N/A
Resistance Level $322.32 $104.38
Average True Range (ATR) 16.93 2.81
MACD -3.50 1.32
Stochastic Oscillator 22.92 57.32

Price Performance

Historical Comparison
PRAX
PFSI

About PRAX Praxis Precision Medicines Inc.

Praxis Precision Medicines Inc is a clinical-stage biopharmaceutical company. It is engaged in translating genetic insights into the development of therapies for patients affected by central nervous system disorders characterized by a neuronal excitation-inhibition imbalance. The company applies genetic insights to the discovery and development of therapies for neurological disorders through two proprietary platforms: Cerebrum and Solidus. It has established a diversified, multimodal CNS portfolio with four clinical-stage product candidates across movement disorders and epilepsy, which include Ulixacaltamide, Relutrigine, Vormatrigine, and Elsunersen. The firm operates in only one segment and is focused on discovering and developing therapies for CNS disorders.

About PFSI PennyMac Financial Services Inc.

PennyMac Financial Services Inc is a specialty financial services firm with a comprehensive mortgage platform and integrated business focused on the production and servicing of U.S. residential mortgage loans. The company operates through two segments: production and servicing. The production segment performs loan origination, acquisition and sale activities. The servicing segment performs loan servicing for newly originated loans.

Share on Social Networks: